Evidence map›Paper›PMID 24895057›Full record

ReviewClinical science (London, England : 1979)2014

The Bioenergetic Health Index: a new concept in mitochondrial translational research.

Balu K Chacko, Philip A Kramer, Saranya Ravi, Gloria A Benavides, Tanecia Mitchell, Brian P Dranka, David Ferrick, Ashwani K Singal, Scott W Ballinger, Shannon M Bailey and 4 more

2 registry-linked trialsOpen access · hybridAbstract readReview
In one paragraph

Review in Clinical science (London, England : 1979), 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to 2 registered trials, which are not on this map. Cited by 231 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
231citing papers in PubMed, 1 pooled it
11.1field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT03323294 completednot on this mapstarted 2017, after this paper: background citation

Bioenergetics and Metabolism in Pediatric Populations

TypeobservationalSponsorArkansas Children's Hospital Research InstituteRan2017 to 2024Enrolled79ConditionsObesity, Type 2 Diabetes Mellitus, Insulin Resistance
NCT05948930 narecruitingnot on this mapstarted 2024, after this paper: background citation

Adaptive Working Memory and Physical Exercise Training to Improve Brain and Mitochondrial Function in MCI

TypeinterventionalSponsorUniversity of Maryland, BaltimoreRan2024 to 2027Enrolled90ConditionsMild Cognitive ImpairmentArmsProgressive aerobic exercise, Adaptive cognitive training, Combined
3 · Its place in the literature

Who cites it

231 citing papers in PubMed, 1 synthesis or guideline pooled it, 372 citations in OpenAlex.

  1. ACG Clinical Guideline: Alcoholic Liver Disease.The American journal of gastroenterology · 2018
    Guideline
  2. Trial
  3. Trial
  4. Trial
  5. Review
  6. Review
  7. Article
  8. Article
  9. Article
  10. Review
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Review
  19. Article
  20. Article

171 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

14 authors at 2 institutions in 1 country.

Balu K Chacko
Philip A Kramer
Saranya Ravi
Gloria A Benavides
Tanecia Mitchell
Brian P Dranka‡Seahorse Bioscience, North Billerica, MA 01862, U.S.A.
David Ferrick‡Seahorse Bioscience, North Billerica, MA 01862, U.S.A.
Ashwani K Singal§Division of Gastroenterology and Hepatology, Department of Internal Medicine, University of Alabama at Birmingham, Birmingham, AL 35294, U.S.A.
Scott W Ballinger
Shannon M Bailey†Department of Pathology, University of Alabama at Birmingham, Birmingham, AL 35294, U.S.A.
Robert W Hardy
Jianhua Zhang
Degui Zhi¶Department of Biostatistics, University of Alabama at Birmingham, Birmingham, AL 35294, U.S.A.
Victor M Darley-Usmar
University of Alabama at Birmingham · USProterixBio (United States) · US

Funding

Coordinating and Bioinformatics Unit for the MMPC/DiaCompU24DK076169 · NIDDK · AUGUSTA UNIVERSITY · PI MCINDOE, RICHARD A. · 2006 to 2018
$42.4M
Why is the prevalence of obesity so high in U.S. Southern States? Regional predictors of BMI and obesity treatment response.P30DK056336 · NIDDK · UNIVERSITY OF ALABAMA AT BIRMINGHAM · PI James O Hill · 2000 to 2026
$31.9M
University of Alabama at Birmingham's Diabetes Research CenterP30DK079626 · NIDDK · UNIVERSITY OF ALABAMA AT BIRMINGHAM · PI Kirk Michael Habegger · 2013 to 2026
$19.5M
UAB-UCSD O'Brien Core Center for Acute Kidney Injury ResearchP30DK079337 · NIDDK · UNIVERSITY OF ALABAMA AT BIRMINGHAM · PI AGARWAL, ANUPAM · 2008 to 2022
$18.3M
MECHANISMS OF HYPERTENSION AND CARDIOVASCULAR DISEASEST32HL007457 · NHLBI · UNIVERSITY OF ALABAMA AT BIRMINGHAM · PI Martin E Young · 1985 to 2026
$8.6M
TRAINING IN CELLULAR PHYSIOLOGY MEMBRANE TRANSPORTT32DK007545 · NIDDK · UNIVERSITY OF ALABAMA AT BIRMINGHAM · PI GUTIERREZ, ORLANDO M · 1987 to 2023
$4.5M
Training Program in Cardiovascular PathophysiologyT32HL007918 · NHLBI · UNIVERSITY OF ALABAMA AT BIRMINGHAM · PI BALLINGER, SCOTT W. · 1999 to 2018
$3.6M
Alpha-synuclein degradation mechanismsR01NS064090 · NINDS · UNIVERSITY OF ALABAMA AT BIRMINGHAM · PI ZHANG, JIANHUA · 2010 to 2014
$1.6M
Alcoholic Liver Dysfunction Potentiation by Hyperlipidemia and Cigarette SmokeR01AA018841 · NIAAA · UNIVERSITY OF ALABAMA AT BIRMINGHAM · PI BAILEY, SHANNON MARIE · 2009 to 2013
$1.5M
Mitochondrial Mechanisms of Hydrogen Sulfide Induced Suspended AnimationR01HL092857 · NHLBI · UNIVERSITY OF ALABAMA AT BIRMINGHAM · PI BAILEY, SHANNON MARIE · 2008 to 2011
$1.4M
NHLBI NIH HHS R01 HL092857NHLBI NIH HHS T32HL007457NHLBI NIH HHS T32 HL007918NHLBI NIH HHS T32HL07918NIAAA NIH HHS R01 AA018841NIDDK NIH HHS DK076169NIDDK NIH HHS P30 DK056336NIDDK NIH HHS P30 DK079337NIDDK NIH HHS P30 DK079626NIDDK NIH HHS T32 DK007545NINDS NIH HHS R01 NS064090
6 · The paper itself

Abstract

Bioenergetics has become central to our understanding of pathological mechanisms, the development of new therapeutic strategies and as a biomarker for disease progression in neurodegeneration, diabetes, cancer and cardiovascular disease. A key concept is that the mitochondrion can act as the 'canary in the coal mine' by serving as an early warning of bioenergetic crisis in patient populations. We propose that new clinical tests to monitor changes in bioenergetics in patient populations are needed to take advantage of the early and sensitive ability of bioenergetics to determine severity and progression in complex and multifactorial diseases. With the recent development of high-throughput assays to measure cellular energetic function in the small number of cells that can be isolated from human blood these clinical tests are now feasible. We have shown that the sequential addition of well-characterized inhibitors of oxidative phosphorylation allows a bioenergetic profile to be measured in cells isolated from normal or pathological samples. From these data we propose that a single value-the Bioenergetic Health Index (BHI)-can be calculated to represent the patient's composite mitochondrial profile for a selected cell type. In the present Hypothesis paper, we discuss how BHI could serve as a dynamic index of bioenergetic health and how it can be measured in platelets and leucocytes. We propose that, ultimately, BHI has the potential to be a new biomarker for assessing patient health with both prognostic and diagnostic value.

Indexed as

Energy MetabolismTranslational Research, BiomedicalAnimalsBiomarkersHumansMitochondriaOxidative StressBiomarkers

Identifiers

PMID24895057
PMCPMC4202728
OpenAlexW2083837493

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.